Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 122   

Articles published

4502 4,928.00 +34.50 (0.71%)
price chart
Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk
Lilly, which co-promoted Actos from 1999 to 2006, was not immediately available to comment. The company has previously said it will be indemnified by Takeda for its losses and expenses from the litigation based on the terms of its agreement with Takeda.
Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award  Businessweek
Takeda Announces Completion of the Post-Marketing Commitment to Submit ...  MarketWatch
Related articles »  
Takeda Responds to Judgment in Diabetes Drug Case
3, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.
Related articles »  
American Diabetes Association and Takeda Launch ConnecT2Day to ...
Takeda Pharmaceuticals U.S.A., Inc., located in Deerfield, Ill., is the U.S. marketing and sales organization of Takeda Pharmaceutical Company Limited, Osaka, Japan. The company has a commercial presence covering more than 70 countries, with particular ...
American Diabetes Association and Takeda Launch ConnecT2Day� to ...  MarketWatch
Related articles »  
Takeda Challenges Claim Construction Rule At High Court
Law360, New York (August 29, 2014, 5:07 PM ET) -- Takeda Pharmaceutical Co. Ltd. has asked the U.S. Supreme Court to nix the Federal Circuit's reversal of an infringement finding against Zydus Pharmaceuticals USA Inc. over its planned generic of the ...
Related articles »  
Company Update: Amgen Inc (NASDAQ:AMGN) - Amgen Submits Biologics ...
It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc.; Takeda Pharmaceutical Company Limited; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, ...
Related articles »  
Takeda Hid Actos Bladder Cancer Risks, Philly Jury Hears
... a woman who claims she developed bladder cancer after taking the diabetes drug Actos told a Philadelphia jury on Thursday that Takeda Pharmaceuticals Co. Ltd. had worked to suppress information about the cancer risks associated with the medication.
Sochi Investment Forum: METRO Cash & Carry and Mitsubishi intensify their ...
In 2012, the construction of a new pharmaceutical factory for the manufacture of prepared medicinal forms that belongs to the Takeda Group was completed. And now the Mitsubishi Company is considering the possibility of establishing the manufacture of ...
Related articles »  
Takeda Announces the Results of Phase 3 Trial of Trelagliptin Succinate (SYR ...
OSAKA, Japan I September 17, 2014 I Takeda Pharmaceutical Company Limited (Takeda) announced the results of a phase 3 trial of trelagliptin succinate (general name, development code: SYR-472) for the treatment of Type 2 diabetes mellitus at the 50th ...
Related articles »  
Biotech Stock News: Orexigen's Obesity Drug Contrave Approved, Stock Set to ...
We note that the company has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development and commercialization of Contrave in North America.
Related articles »  
Orexigen Therapeutics (OREX), Takeda Enter Manufacturing Services ...
In preparation for the potential launch of NB32, Orexigen Therapeutics (Nasdaq: OREX) and Takeda Pharmaceutical Company Limited (�Takeda�) entered into a Manufacturing Services Agreement, dated September 2, 2014 (the �Agreement�), in accordance ...